Russell Investments Group
ACHN

Russell Investments Group’s Achillion Pharmaceuticals ACHN Stock Holding History

Russell Investments Group’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-37,100
Closed -$110K – 3026
2019
Q1 		$110K Buy
37,100
+21,500
+138% +$52.8K ﹤0.01% 2720
2018
Q4 		$25K Sell
15,600
-16,200
-51% -$45.8K ﹤0.01% 2852
2018
Q3 		$117K Sell
31,800
-1,500
-5% -$4.47K ﹤0.01% 2739
2018
Q2 		$94K Sell
33,300
-8,000
-19% -$27.2K ﹤0.01% 2750
2018
Q1 		$153K Hold
41,300
– – ﹤0.01% 2701
2017
Q4 		$122K Buy
+41,300
New +$150K ﹤0.01% 2744
2017
Q2 		– Sell
-10,851
Closed -$46K – 3095
2017
Q1 		$46K Sell
10,851
-28,660
-73% -$119K ﹤0.01% 2910
2016
Q4 		$162K Buy
+39,511
New +$210K ﹤0.01% 2759

Other funds holding ACHN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Russell Investments Group's ACHN Position: Q2 2019 in Review

Russell Investments Group sold out of Achillion Pharmaceuticals (ACHN) in Q2 2019, closing a stake of 37,100 shares — an estimated $110K sold.

Russell Investments Group first reported a position in ACHN in Q4 2016 and held it in 8 quarters. The position peaked at $162K in Q4 2016. 114 funds tracked by Wall St. Rank hold ACHN as of Q2 2019.

  • Russell Investments Group reported no remaining Achillion Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Russell Investments Group sold 37,100 Achillion Pharmaceuticals shares in Q2 2019, an estimated $110K.
  • Russell Investments Group first reported a position in Achillion Pharmaceuticals in Q4 2016 and held it in 8 quarters.
  • Russell Investments Group's Achillion Pharmaceuticals position peaked at $162K in Q4 2016.
  • 114 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q2 2019.

Based on Russell Investments Group's 13F filing for Q2 2019, filed 9 Aug 2019.